These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33664458)

  • 1. LSD1-mediated stabilization of SEPT6 protein activates the TGF-β1 pathway and regulates non-small-cell lung cancer metastasis.
    Hong Y; Li X; Zhu J
    Cancer Gene Ther; 2022 Feb; 29(2):189-201. PubMed ID: 33664458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer.
    Lv T; Yuan D; Miao X; Lv Y; Zhan P; Shen X; Song Y
    PLoS One; 2012; 7(4):e35065. PubMed ID: 22493729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FMNL1 down-regulation suppresses bone metastasis through reducing TGF-β1 expression in non-small cell lung cancer (NSCLC).
    Yang XY; Liao JJ; Xue WR
    Biomed Pharmacother; 2019 Sep; 117():109126. PubMed ID: 31387165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA BX357664 inhibits the proliferation and invasion of non-small cell lung cancer cells.
    Yang J; Du YM; Li B
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):660-669. PubMed ID: 30720174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TdIF1-LSD1 Axis Regulates Epithelial-Mesenchymal Transition and Metastasis via Histone Demethylation of E-Cadherin Promoter in Lung Cancer.
    Liu Q; Xiong J; Xu D; Hao N; Zhang Y; Sang Y; Wang Z; Zheng X; Min J; Diao H; Raphael J; Maleki Vareki S; Koropatnick J; Min W
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogene LSD1 is epigenetically suppressed by miR-137 overexpression in human non-small cell lung cancer.
    Zhang X; Zhang X; Yu B; Hu R; Hao L
    Biochimie; 2017 Jun; 137():12-19. PubMed ID: 28223039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1.
    Zhu FY; Zhang SR; Wang LH; Wu WD; Zhao H
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8377-8390. PubMed ID: 31646568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA NBR2 Regulates Cancer Cell Stemness and Predicts Survival in Non-small Cell Cancer Patients by Downregulating TGF-β1.
    Huang J; Yu Q; Zhang J; Lu W; Liu Q; Chu Y; Zhou Y; Tu R; Zhou H; Wang Q
    Curr Pharm Biotechnol; 2023; 24(8):1059-1069. PubMed ID: 35909269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference of lysine-specific demethylase 1 inhibits cellular invasion and proliferation in vivo in gastric cancer MKN-28 cells.
    Li Y; Tian X; Sui CG; Jiang YH; Liu YP; Meng FD
    Biomed Pharmacother; 2016 Aug; 82():498-508. PubMed ID: 27470390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysine-specific demethylase-1 regulates fibroblast activation in pulmonary fibrosis via TGF-β1/Smad3 pathway.
    Pan X; Li J; Tu X; Wu C; Liu H; Luo Y; Dong X; Li X; Pan LL; Sun J
    Pharmacol Res; 2020 Feb; 152():104592. PubMed ID: 31830521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRA ANCR Inhibits Non-Small Cell Lung Cancer Cell Migration and Invasion by Inactivating TGF-β Pathway.
    Wang S; Lan F; Xia Y
    Med Sci Monit; 2018 Aug; 24():6002-6009. PubMed ID: 30154397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysine-specific demethylase 1 induced epithelial-mesenchymal transition and promoted renal fibrosis through Jagged-1/Notch signaling pathway.
    Zhang H; Xing J; Zhao L
    Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S203-S214. PubMed ID: 34396798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA HAND2-AS1 inhibits non-small cell lung cancer migration, invasion and maintains cell stemness through the interactions with TGF-β1.
    Miao F; Chen J; Shi M; Song Y; Chen Z; Pang L
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM66 hastens the malignant progression of non-small cell lung cancer via modulating MMP9-mediated TGF-β/SMAD pathway.
    Chen W; Zhang Y; Fang Z; Qi W; Xu Y
    Cytokine; 2022 May; 153():155831. PubMed ID: 35301175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA WT1-AS over-expression inhibits non-small cell lung cancer cell stemness by down-regulating TGF-β1.
    Jiang X; Wang J; Fang L
    BMC Pulm Med; 2020 Apr; 20(1):113. PubMed ID: 32349718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pseudogene DUXAP10 promotes an aggressive phenotype through binding with LSD1 and repressing LATS2 and RRAD in non small cell lung cancer.
    Wei CC; Nie FQ; Jiang LL; Chen QN; Chen ZY; Chen X; Pan X; Liu ZL; Lu BB; Wang ZX
    Oncotarget; 2017 Jan; 8(3):5233-5246. PubMed ID: 28029651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone demethylase PHF8 promotes cell growth and metastasis of non-small-cell lung cancer through activating Wnt/β-catenin signaling pathway.
    Hu Y; Mu H; Yang Y
    Histol Histopathol; 2021 Aug; 36(8):869-877. PubMed ID: 34100557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
    Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
    Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
    Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W
    Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of long intergenic noncoding RNA 00673 promotes tumor proliferation via LSD1 interaction and repression of NCALD in non-small-cell lung cancer.
    Shi X; Ma C; Zhu Q; Yuan D; Sun M; Gu X; Wu G; Lv T; Song Y
    Oncotarget; 2016 May; 7(18):25558-75. PubMed ID: 27027352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.